Acuta Capital Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-770,000
| Closed | -$11.2M | – | 48 |
|
|
2020
Q1 | $11.2M | Sell |
770,000
-287,500
| -27% | -$4.17M | 5.42% | 6 |
|
|
2019
Q4 | $21.4M | Buy |
1,057,500
+207,500
| +24% | +$4.2M | 5.31% | 4 |
|
|
2019
Q3 | $4.54M | Sell |
850,000
-85,000
| -9% | -$454K | 3.28% | 11 |
|
|
2019
Q2 | $6.15M | Buy |
+935,000
| New | +$6.15M | 2.19% | 17 |
|
|
2017
Q2 | – | Sell |
-400,000
| Closed | -$2.94M | – | 37 |
|
|
2017
Q1 | $2.94M | Sell |
400,000
-600,000
| -60% | -$4.4M | 0.7% | 28 |
|
|
2016
Q4 | $2.1M | Buy |
+1,000,000
| New | +$2.1M | 0.78% | 25 |
|
|
2015
Q4 | – | Sell |
-377,427
| Closed | -$1.07M | – | 51 |
|
|
2015
Q3 | $1.07M | Sell |
377,427
-147,324
| -28% | -$418K | 0.62% | 38 |
|
|
2015
Q2 | $1.59M | Buy |
524,751
+94,751
| +22% | +$286K | 0.98% | 28 |
|
|
2015
Q1 | $1.88M | Buy |
+430,000
| New | +$1.88M | 1.58% | 20 |
|